Article Information
History
- February 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Davina Biel1,†,
- Matthias Brendel2,
- Anna Rubinski1,
- Katharina Buerger1,3,
- Daniel Janowitz1,
- Martin Dichgans1,3,4,
- Nicolai Franzmeier1,†,
- for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)*
- 1Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, 81377 Munich,Germany
- 2Department of Nuclear Medicine, University Hospital, LMU Munich, 80336 Munich, Germany
- 3German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany
- 4Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- ↵†Corresponding authors:
Nicolai Franzmeier, e-mail: Nicolai.franzmeier{at}med.uni-muenchen.de Davina Biel, e-mail: Davina.biel{at}med.uni-muenchen.de
Posted February 08, 2021.
Tau-PET and in vivo Braak-staging as a prognostic marker in Alzheimer’s disease
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos